Fatal postlymphoma chemotherapy hepatitis B reactivation secondary to the emergence of a YMDD mutant strain with lamivudine resistance in a noncirrhotic patient

Joanna K. Law, Jaber Al Ali, P. Richard Harrigan, Christopher H. Sherlock, Kerry J. Savage, Eric M. Yoshida

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Fatal postlymphoma chemotherapy hepatitis B reactivation secondary to the emergence of a YMDD mutant strain with lamivudine resistance in a noncirrhotic patient'. Together they form a unique fingerprint.

Medicine & Life Sciences